0000950170-24-039316.txt : 20240401 0000950170-24-039316.hdr.sgml : 20240401 20240401160842 ACCESSION NUMBER: 0000950170-24-039316 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240328 FILED AS OF DATE: 20240401 DATE AS OF CHANGE: 20240401 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: McLoughlin Sean CENTRAL INDEX KEY: 0002007879 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41365 FILM NUMBER: 24809249 MAIL ADDRESS: STREET 1: C/O HILLEVAX, INC. STREET 2: 321 HARRISON AVE, SUITE 500 CITY: BOSTON STATE: MA ZIP: 021118 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HilleVax, Inc. CENTRAL INDEX KEY: 0001888012 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 321 HARRISON AVE, SUITE 500 CITY: BOSTON STATE: MA ZIP: 02118 BUSINESS PHONE: (617) 213-5054 MAIL ADDRESS: STREET 1: 321 HARRISON AVE, SUITE 500 CITY: BOSTON STATE: MA ZIP: 02118 4 1 ownership.xml 4 X0508 4 2024-03-28 0001888012 HilleVax, Inc. HLVX 0002007879 McLoughlin Sean C/O HILLEVAX, INC. 321 HARRISON AVE, SUITE 500 BOSTON MA 02118 false true false false Chief Operating Officer false Common Stock 2024-03-28 4 P false 1250 16.98 A 1250 D /s/ Paul Bavier, Attorney-in-Fact for Sean McLoughlin 2024-04-01